The IDSA released 2025 guidelines for treating mild to moderate COVID-19, emphasizing risk-based antiviral use to prevent ...

Researchers continue looking at existing medicine for help in the fight against the novel coronavirus, because those drugs already exist and could quickly make a big difference. The latest lead for ...

The closest-ever detailed look at a key enzyme inside the virus that causes COVID-19 could lead to more effective treatment ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

CHICAGO (WLS) -- As the COVID-19 pandemic spreads, hospitals around the world have begun testing convalescent plasma as a potential treatment. The University of Chicago Medicine is one facility who is ...

There’s no evidence showing that remdesivir, the first treatment approved for COVID-19, killed patients taking the drug. The antiviral drug is still approved by the U.S. Food and Drug Administration ...

Add Yahoo as a preferred source to see more of our stories on Google. A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally ...